Sean E. Browne - Oct 15, 2023 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role: President and CEO, Director
Signature: /s/ Amy Culbert, attorney-in-fact
Stock symbol: XTNT
Transactions as of: Oct 15, 2023
Transactions value $: -$120,659
Form type: 4
Date filed: 10/17/2023, 04:43 PM
Previous filing: Aug 17, 2023
Next filing: Apr 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XTNT	Common Stock	Tax liability	-$121K	-112K	-6.65%	$1.08	1.57M	Oct 15, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 174,216 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 433,024 shares to be issued upon vesting pursuant to restricted stock awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended from time to time, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.

Content

Includes 174,216 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 433,024 shares to be issued upon vesting pursuant to restricted stock awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended from time to time, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.